Skip to main content
. 2020 Sep 13;9(19):e017793. doi: 10.1161/JAHA.120.017793

Figure 3. Factors associated with financial toxicity among individuals with atherosclerotic cardiovascular disease.

Figure 3

Data from studies by Khera et al, 15 Valero‐Elizondo et al, 23 and Khera et al. 31 ASCVD indicates atherosclerotic cardiovascular disease; CHE, catastrophic healthcare expenditures; CRN, cost‐related medication nonadherence; and OOP, out‐of‐pocket.